Honbill Pharma Private Limited
About Honbill Pharma Private Limited
Data last updated:
Honbill Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 12 September 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2022PTC390309.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10,000. It is led by directors Renu Ojha (Whole-Time Director) and Sanjay Kumar Ojha (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 24 Guru Nanak Wadi Shanti Nagar Cst Road West Mumbai, Maharashtra, India – 400070.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.29 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹4,610 (net margin 3.6%) and EBITDA of ₹6,230 (EBITDA margin 4.8%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address24 Guru Nanak Wadi Shanti Nagar Cst Road West Mumbai, Maharashtra, India – 400070
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Honbill Pharma Private Limited
The main business activity of Honbill Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Honbill Pharma Private Limited FY 2025 filings available
Honbill Pharma Private Limited reported revenue of ₹1.29 Lakh (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Honbill Pharma Private Limited
Revenue rose 19% in the latest year. EBITDA rose 9% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Honbill Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹6,230 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4,610 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Honbill Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 4.8% | •••• | •••• |
| Net Profit Margin | 3.6% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Honbill Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Honbill Pharma Private Limited
Honbill Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Indiherb Remedies Private Limited | ₹1.29 Lakh (FY 2024) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| HMB Steel Private Limited | ₹1.29 Lakh (FY 2025) | •••• | •••• | 29.0% | •••• | Kolkata, West Bengal, India |
| Levin Paintech Private Limited | ₹1.29 Lakh (FY 2023) | •••• | •••• | -59.0% | •••• | Ahmedabad, Gujarat, India |
| Tondak Resources Private Limited | ₹1.29 Lakh (FY 2019) | •••• | •••• | •••• | Delhi, India | |
| Oddison India Multitrade Private Limited | ₹1.29 Lakh (FY 2018) | •••• | •••• | -73.0% | •••• | Bhubaneswar, Odisha, India |
| Honbill Pharma Private Limited this company | ₹1.29 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Mumbai, Maharashtra, India |
| Laststar Captures Private Limited | ₹1.29 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Salem, Tamil Nadu, India |
| Xectus Infra Private Limited | ₹1.29 Lakh (FY 2022) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Lifesap Private Limited | ₹1.29 Lakh (FY 2024) | •••• | •••• | -36.0% | •••• | Kanpur, Uttar Pradesh, India |
| Deorahi Ayurvedic India Private Limited | ₹1.29 Lakh (FY 2021) | •••• | •••• | 28.0% | •••• | Baruipur, West Bengal, India |
| Yatoshan Marketing Private Limited | ₹1.29 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Honbill Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Honbill Pharma Private Limited
Honbill Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Renu Ojha | Whole-Time Director | 12 Sep 2022 | 4 Years 1 Months | Current |
| Sanjay Kumar Ojha Also directs: Admix Healthcare Private Limited | Whole-Time Director | 12 Sep 2022 | 4 Years 1 Months | Current |
Charges & Borrowings of Honbill Pharma Private Limited
Honbill Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Honbill Pharma Private Limited
Employment history and EPFO contributions of people linked to Honbill Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Honbill Pharma Private Limited
Honbill Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Renu Ojha was appointed as Whole-Time Director on 12 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Honbill Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Honbill Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Honbill Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Honbill Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Honbill Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Honbill Pharma Private Limited
Honbill Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 12 September 2022 (4+ years old) and is registered under CIN U51909MH2022PTC390309.
Honbill Pharma reported revenue of ₹1.29 Lakh for FY 2025 (up 19% YoY).
Honbill Pharma has 2 current directors:
- Renu Ojha - Whole-Time Director
- Sanjay Kumar Ojha - Whole-Time Director
Honbill Pharma reported a net profit of ₹4,610 (net margin 3.6%) and EBITDA of ₹6,230 (EBITDA margin 4.8%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Honbill Pharma is U51909MH2022PTC390309. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Honbill Pharma was incorporated on 12 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Honbill Pharma by revenue are Indiherb Remedies Private Limited, HMB Steel Private Limited, Levin Paintech Private Limited, Tondak Resources Private Limited, Oddison India Multitrade Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Renu Ojha was appointed as Whole-Time Director on 12 Sep 2022. Sanjay Kumar Ojha was appointed as Whole-Time Director on 12 Sep 2022.
The registered office of Honbill Pharma is at 24 Guru Nanak Wadi Shanti Nagar Cst Road West Mumbai, Maharashtra, India – 400070.
Honbill Pharma has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10,000.
Honbill Pharma operates in the trading industry, in the specialty segment.